Answers are grounded in this paper and cite their sources.
By integrating different types of catalysts in the same system, hybrid catalysis emerges as an attractive and competitive approach. Within the framework of valorizing sustainably sourced bio-based products, we herein present a synthetic method for producing amides from alcohols and the bio-sourced 5-aminomethyl-2-furancarboxylic acid (AMFC). This approach utilizes supported gold metal nanoparticles as heterogeneous chemocatalysts, in conjunction with an acyl-coenzyme A ligase (ACL). By combining the actions of these catalysts, aliphatic mono- and di-alcohols are converted to the corresponding AMFC-derived amides with yields of up to 65% in aqueous buffer at 60 °C. This process requires only the addition of the enzyme and associated reactants in the same vessel for the second step in an one-pot/two-steps procedure.
No takes yet. Share an insight, caveat, or question.
Bisel et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: